215 related articles for article (PubMed ID: 3780047)
21. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
Eda R; Townley RG; Hopp RJ
Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of eosinophil leukocyte chemotaxis by a factor in normal human serum (SEF).
Czarnetzki BM
Int Arch Allergy Appl Immunol; 1979; 60(3):315-24. PubMed ID: 489135
[TBL] [Abstract][Full Text] [Related]
23. Mediation of leukocyte components of inflammatory reactions by lipoxygenase products of arachidonic acid.
Goetzl EJ; Goldman DW; Naccache PH; Sha'afi RI; Pickett WC
Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():273-82. PubMed ID: 6283846
[TBL] [Abstract][Full Text] [Related]
24. Eosinophil locomotion and the release of IL-3 and IL-5 by allergen-stimulated mononuclear cells are effectively downregulated in vitro by budesonide.
Lantero S; Sacco O; Scala C; Morelli MC; Rossi GA
Clin Exp Allergy; 1996 Jun; 26(6):656-64. PubMed ID: 8809423
[TBL] [Abstract][Full Text] [Related]
25. Contrasting responses to multiple chemotactic stimuli in transendothelial migration: heterologous desensitization in neutrophils and augmentation of migration in eosinophils.
Kitayama J; Carr MW; Roth SJ; Buccola J; Springer TA
J Immunol; 1997 Mar; 158(5):2340-9. PubMed ID: 9036983
[TBL] [Abstract][Full Text] [Related]
26. Purification and characterization of a high molecular weight eosinophil chemotactic factor from Schistosoma japonicum eggs.
Owhashi M; Ishii A
J Immunol; 1982 Nov; 129(5):2226-31. PubMed ID: 6889620
[TBL] [Abstract][Full Text] [Related]
27. [Type IV allergic reaction (delayed type)].
Hirashima M
Nihon Rinsho; 1993 Mar; 51(3):669-74. PubMed ID: 8492441
[TBL] [Abstract][Full Text] [Related]
28. Isolation of an eosinophil chemotactic lymphokine as a natural mediator for eosinophil chemotaxis from concanavalin A-induced skin reaction sites in guinea-pigs.
Hirashima M; Tashiro K; Sakata K; Hirashima M
Clin Exp Immunol; 1984 Jul; 57(1):211-9. PubMed ID: 6378462
[TBL] [Abstract][Full Text] [Related]
29. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
Liu L; Zuurbier AE; Mul FP; Verhoeven AJ; Lutter R; Knol EF; Roos D
J Immunol; 1998 Sep; 161(6):3064-70. PubMed ID: 9743372
[TBL] [Abstract][Full Text] [Related]
30. Effects of novel lipoxygenase products on migration of eosinophils and neutrophils in vitro.
Udén AM; Palmblad J; Lindgren JA; Malmsten C
Int Arch Allergy Appl Immunol; 1983; 72(1):91-3. PubMed ID: 6307891
[TBL] [Abstract][Full Text] [Related]
31. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
Beswick PH; Kay AB
Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
[TBL] [Abstract][Full Text] [Related]
32. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700.
Kim YJ; Prussin C; Martin B; Law MA; Haverty TP; Nutman TB; Klion AD
J Allergy Clin Immunol; 2004 Dec; 114(6):1449-55. PubMed ID: 15577851
[TBL] [Abstract][Full Text] [Related]
33. Presence of antibodies against endothelial cells in the sera of patients with episodic angioedema and hypereosinophilia.
Lassalle P; Gosset P; Gruart V; Prin L; Capron M; Lagrue G; Kusnierz JP; Tonnel AB; Capron A
Clin Exp Immunol; 1990 Oct; 82(1):38-43. PubMed ID: 2208795
[TBL] [Abstract][Full Text] [Related]
34. Comparative studies on eosinophil chemotactic factors during leukocyte migration under agarose.
Fischer N; Czarnetzki BM
J Invest Dermatol; 1982 Oct; 79(4):222-6. PubMed ID: 7130738
[TBL] [Abstract][Full Text] [Related]
35. Study of release of eosinophil cationic proteins (ECP and EPX) in the hypereosinophilic syndrome (HES) and other hypereosinophilic conditions.
Bobbio-Pallavicini E; Confalonieri M; Tacconi F; Mainardi E; Della Porta R; Ceccato D; Maccario R; De Amici M
Panminerva Med; 1998 Sep; 40(3):186-90. PubMed ID: 9785914
[TBL] [Abstract][Full Text] [Related]
36. Leukotriene B4 mediates substance P-induced granulocyte infiltration into mouse skin. Comparison with antigen-induced granulocyte infiltration.
Iwamoto I; Tomoe S; Tomioka H; Yoshida S
J Immunol; 1993 Aug; 151(4):2116-23. PubMed ID: 7688393
[TBL] [Abstract][Full Text] [Related]
37. Chemotactic capabilities of HL-60 human myeloid leukemia cells differentiated to eosinophils.
Howe RS; Fischkoff SA; Rossi RM; Lyttle CR
Exp Hematol; 1990 May; 18(4):299-303. PubMed ID: 2323365
[TBL] [Abstract][Full Text] [Related]
38. Comparison of platelet-activating factor-induced chemotaxis of normodense and hypodense eosinophils.
Little MM; Casale TB
J Allergy Clin Immunol; 1991 Aug; 88(2):187-92. PubMed ID: 1880319
[TBL] [Abstract][Full Text] [Related]
39. RANTES is a chemotactic and activating factor for human eosinophils.
Alam R; Stafford S; Forsythe P; Harrison R; Faubion D; Lett-Brown MA; Grant JA
J Immunol; 1993 Apr; 150(8 Pt 1):3442-8. PubMed ID: 7682241
[TBL] [Abstract][Full Text] [Related]
40. A novel eosinophil chemotactic factor derived from a histiocytic lymphoma of the central nervous system.
Goetzl EJ; Rothenberg J; Weber EL; Sinn CM; Austen KF
Clin Exp Immunol; 1980 May; 40(2):249-55. PubMed ID: 7438536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
